TP53 and cancer: Furthermore, P53 expression was significantly elevated in both the nanocurcumin and combined training + nanocurcumin groups in comparison with the cancer and 4‐week cancer controls, thereby suggesting an augmentation of tumor‐suppressive activity (Naghizadeh et al. 2024).